NeuroBo to begin clinical trial of NB-01 in adult patients with diabetic neuropathic pain

NeuroBo to begin clinical trial of NB-01 in adult patients with diabetic neuropathic pain

Source: 
Pharmaceutical Business Review
snippet: 
NeuroBo Pharmaceuticals has announced its plans to initiate a phase III trial to evaluate the efficacy of its lead drug, NB-01, in diabetic neuropathic pain in early second quarter of this year.